Search - tctmd.com

Displaying 261 - 280 of 323

Sort: Relevancy | Date

News Conference News EuroPCR 2014

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

Yael L. Maxwell

May 21, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

Coronary Microvascular Dysfunction Common in Both Sexes, Predicts MACE

May 07, 2014

News Daily News

REMINDER Study: Eplerenone Safe, Effective in STEMI Patients Without Heart Failure

May 05, 2014

News Daily News

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Yael L. Maxwell

May 01, 2014

News Daily News

Radial Access in Primary PCI Offers Sustained Survival Benefit Even After Long Delays

Caitlin E. Cox

April 18, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

News Daily News

FAST-MI Registry: Fibrinolysis, Primary PCI Yield Similar 5-Year Survival in STEMI Patients

L.A. McKeown

April 03, 2014

News Conference News ACC 2014

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

Jason Kahn

March 31, 2014

News Daily News

Los Andamiajes Bioabsorbibles resultan Prometedores en Pacientes STEMI Seleccionados

Yael L. Maxwell

January 09, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

January 01, 2014

News Conference News TCT 2013

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

October 30, 2013

News Daily News

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

L.A. McKeown

September 27, 2013

News Daily News

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

L.A. McKeown

September 20, 2013

News Daily News

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

L.A. McKeown

September 20, 2013

News Daily News

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

July 24, 2013

News Daily News

Mayor mortalidad cardíaca a largo plazo con la primera generación de SLF vs. SMD para STEMI

July 24, 2013

Advertisement

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

Coronary Microvascular Dysfunction Common in Both Sexes, Predicts MACE

REMINDER Study: Eplerenone Safe, Effective in STEMI Patients Without Heart Failure

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Radial Access in Primary PCI Offers Sustained Survival Benefit Even After Long Delays

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

FAST-MI Registry: Fibrinolysis, Primary PCI Yield Similar 5-Year Survival in STEMI Patients

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

Los Andamiajes Bioabsorbibles resultan Prometedores en Pacientes STEMI Seleccionados

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

Mayor mortalidad cardíaca a largo plazo con la primera generación de SLF vs. SMD para STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content